文献速递免疫规划妇幼与学校卫生

观点各异:对孕妇参与母体疫苗试验的看法

A mix of views: Perspectives on pregnant women's participation in maternal vaccine trials.
PubMed 文献 · Vaccine · 2025-08-31

该研究在乌干达坎帕拉采用焦点小组讨论、深度访谈和关键知情人访谈,于2022年10月至2023年2月调查了56名孕妇或哺乳期妇女、其伴侣、家庭成员、朋友及其他利益相关者对参与B族链球菌母体疫苗试验的看法。参与者表达了对孕妇及其胎儿安全的不同担忧,孕妇主要关注婴儿安全,伴侣和家庭成员担忧母婴安全,朋友更关注疫苗本身,社区成员对疫苗普遍持怀疑态度。结论认为建立信任、提供准确信息和透明沟通对提高疫苗试验参与度至关重要。

要点

  • 孕妇主要关注婴儿安全,伴侣和家庭成员担忧母婴安全。
  • 朋友更关注疫苗本身,社区成员对疫苗普遍持怀疑态度。
  • 建立信任和透明沟通是提高疫苗试验参与度的关键步骤。

核心结论

  • 建立信任、提供准确信息以及就母体疫苗的安全性和意图进行透明沟通,是促进理解和增加疫苗试验参与度的关键步骤。
  • 需要与目标研究人群讨论破除迷思、纠正误解并解决导致犹豫的潜在恐惧。

研究设计与样本

  • 横断面研究,嵌套于在国家转诊医院开展的B族链球菌母体疫苗试验中。
  • 于2022年10月至2023年2月开展焦点小组讨论、深度访谈和关键知情人访谈,共56名参与者:36名孕妇或哺乳期妇女、5名未参与试验的妇女、5名试验中妇女的伴侣、5名医护人员和5名社区利益相关者。

主要发现

  • 参与者对孕妇参与母体疫苗试验表达了各种担忧。
  • 家庭成员、伴侣、朋友和社区成员表达了对孕妇及其未出生婴儿安全的担忧,但具体担忧的性质和对疫苗意图的关注点不同。
  • 孕妇主要关注其婴儿的安全,而伴侣和家庭成员担忧母婴安全。
  • 朋友更关注疫苗本身,社区成员对疫苗普遍持怀疑态度、害怕可能的伤害并质疑疫苗开发的意图。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to investigate perspectives on participation in a Group B Streptococcus (GBS) maternal vaccine trial among pregnant women, their partners, family members, friends and other stakeholders in Kampala, Uganda. METHODS: We conducted focus group discussions, in-depth interviews and key informant interviews from October 2022 to February 2023 with 56 participants: 36 pregnant or breastfeeding women, 5 women not in the trial, 5 partners of women in trial, 5 healthcare workers, and 5 community stakeholders. This cross-sectional study was embedded within a GBS maternal vaccine trial conducted at the national referral hospital. All study participants were recruited after seeking hospital administrative approval and individual consent. Women taking part in the GBS trial were contacted by phone and invited to the hospital for detailed information during their follow-up visits. Eligible pregnant women were aged 18-39, and participating in a GBS maternal vaccine trial. Their identifiers were shared with the social science team after approval. With the support of the health visitors, the women were contacted. Non-trial participants with similar characteristics were recruited through antenatal clinic staff. Both groups were purposively sampled across age brackets (18-24 years, 25-32 years, 33-39 years) for discussion groups. Women's partners were recruited through contact information provided by the women, and community stakeholders were mobilized with assistance from a Community Advisory Board member. Healthcare workers involved in the trial, including doctors, nurses, and midwives, as well as a research ethics committee member, were directly approached and invited to participate. All participants provided informed consent. RESULTS: The participants expressed various concerns about participation of pregnant women in maternal vaccine trials. While family members, partners, friends, and community members, expressed concern for the safety of pregnant women and their unborn babies, the specific nature of these concerns and the focus on vaccine intentions differed. Pregnant women primarily focused on the safety of their babies, while partners and family members worried about both maternal and fetal safety. Friends were more concerned about the vaccine itself, community members were suspicious of vaccines in general, fear of possible harm and questioned the intent for vaccine development. CONCLUSIONS: Building trust, providing accurate information, and engaging in transparent communication about the safety and intentions of maternal vaccines are crucial steps in fostering understanding and increasing participation in vaccine trials. Efforts to dispel myths, correct misconceptions, and address the underlying fears that contribute to hesitancy within these diverse stakeholder groups need to be discussed with targeted study populations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nalubega P, Namugumya R, Kyohere M, et al. A mix of views: Perspectives on pregnant women's participation in maternal vaccine trials. Vaccine. 2025. PMID: 40889445. doi:10.1016/j.vaccine.2025.127627

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。